Clinical study on the effect of anti osteoporosis treatment on total knee arthroplastyin patients with knee osteoarthritis
膝关节骨性关节炎患者抗骨质疏松治疗对全膝关节置换术后效果影响的临床研究

摘要

目的 分析膝关节骨性关节炎患者在选择全膝关节置换术治疗前，给予抗骨质疏松治疗的价值。方法 筛选80例膝关节骨性关节炎患者为样本，样本均选自2021年3月～2022年3月，作随机分组处理后按照1:1的比例分组，对照组共计40例不实施抗骨质疏松治疗，观察组共计40例术前6个月展开抗骨质疏松治疗，对比2组临床疗效、临床指标、骨密度。结果 观察组临床疗效（95.00%）测评值，较对照组（80.00%）明显升高（P<0.05）；观察组VAS评分低于对照组，HSS评分高于对照组（P<0.05）；观察组骨密度含量，较对照组升高（P<0.05）。结论 膝关节骨性关节炎患者在实施全膝关节置换术前，进行为期6个月的抗骨质疏松治疗可提升整体疗效及骨密度，同时可改善机体关节功能，值得借鉴。

Abstract

Objective to analyze the value of anti osteoporosis treatment in patients with knee osteoarthritis before total knee arthroplasty.
Methods 80 patients of knee OA were screened as samples, all selected from March 2021 to March 2022. They were randomly divided into groups according to the ratio of 1:1. A total of 40 patients in the control group were not treated with anti osteoporosis treatment, and a total of 40 patients in the observation group were treated with anti osteoporosis treatment 6 months before operation. The clinical efficacy, clinical indicators and bone mineral density of the two groups were compared.
Results the evaluation value of clinical efficacy (95.00%) in the observation group was significantly higher than that in the control group (80.00%) (P<0.05); The VAS score of the observation group was lower than that of the control group, and the HSS score was higher than that of the control group (P<0.05); The content of bone mineral density in the observation group was higher than that in the control group (P<0.05).
Conclusion   before total knee arthroplasty, anti osteoporosis treatment for 6 months in patients with knee osteoarthritis can improve the overall curative effect and bone mineral density, and improve the body joint function, which is worthy of reference.